Kᵢ

Advancing Cannabinoid Science

Cannabinoid molecules have untapped potential as a therapeutic platform that is seemingly unprecedented in both the range of system targets and clinical indications that are addressed – while having an incredible safety/toxicity profile.

Exploration

Join the Ki Exploration of scientists, disease experts, business leaders, investors, and philanthropists gathered to advance the therapeutic potential of cannabinoids.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Frequently Asked Questions

Who are the Science Partners of the Collective?

Research institutes, universities, neurology/central nervous system disease-focused scientists & organizations, cannabinoid-focused scientists & MDs.  All these constituents have a vested interest in advancing the science of cannabinoids as a potentially powerful therapeutic platform.  

Who are the Capital Partners of the Collective?

Life Science Investment Funds, Cannabis Investment Funds, Purpose-driven, legacy-focused investment groups such as Family Offices, and Disease-Focused Philanthropists are all represented.

What do you mean by “bringing REAL SCIENCE” to cannabinoids?

As alternatives to traditional therapies, millions of consumers seemingly believe in the potential -- self-dosing with “over-the-counter” cannabis-based products.  But these products have unregulated, highly variable formulations and no scientifically validated efficacy data.

How big is the potential market for cannabinoid-derived therapeutics?

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Why has cannabinoid scientific research been limited?

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Why do cannabinoids have promise as potential therapies for difficult diseases? 

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Why do cannabinoids have promise as potential therapies for difficult diseases?

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Are there any FDA approved cannabis derived drugs? 

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.